| Net (loss) income | 6.7M |
| Deferred tax benefit | 3.12M |
| Depreciation and amortization | 9.8M |
| Equity compensation expense | 2.14M |
| Write off and amortization of debt issuance costs | 439K |
| Loss on disposal of assets | 828K |
| Provision for losses on accounts receivable | 304K |
| Change in fair value of theoretical swap derivative | -244K |
| Reserve for potential legal liability | 0 |
| Changes in certain other assets and liabilities | |
| Net cash provided by operating activities | 17.37M |
| Purchases of property and equipment | |
| Net cash used in investing activities | -5.17M |
| Net proceeds from issuance of common stock | -72K |
| Repayment of 2007 Notes | -9M |
| Repayment of capital lease obligations | |
| Net cash used in financing activities | -9.07M |
| Net decrease in cash and cash equivalents | 3.13M |
| Cash and cash equivalents at beginning of year | 31.29M |
| Cash and cash equivalents at end of period | 34.46M |